Viking Global Opportunities Portfolio GP LLC — SEC Form 4 filings
SEC reporting owner CIK 1629472. 8 Form 4 filings on record with FilingPulse; latest filed 2025-10-09.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-28 to 2025-10-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 5 filings — 11,906,015 shares, $450,810,614 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 3,500,000 shares @ $44.00 ($154,000,000) in BridgeBio Pharma, Inc., filed 2025-07-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | 10% owner | 2 | — | 2 legs · 6,565,616 sh · $260,989,998 | — |
| APi Group Corp (APG) | 10% owner | 3 | — | 4 legs · 4,990,399 sh · $178,533,116 | 6 |
| Inhibrx Biosciences, Inc. (INBX) | 10% owner | 1 | — | 3 legs · 350,000 sh · $11,287,500 | — |
| Inhibrx, Inc. (INBX) | 10% owner | 1 | — | — | 4 |
| RayzeBio, Inc. (RYZB) | 10% owner | 1 | — | — | 2 |
Form 4 filings — Viking Global Opportunities Portfolio GP LLC
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-10-09 | 4 | Inhibrx Biosciences, Inc. (INBX) jointly with VIKING GLOBAL INVESTORS LP, Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, HALVORSEN OLE ANDREAS, Ott David C., Shabet Rose Sharon | Sale (S): 308,643 @ $32.25 · Sale (S): 16,315 @ $32.25 · Sale (S): 25,042 @ $32.25 | EDGAR |
| 2025-07-01 | 4 | BridgeBio Pharma, Inc. (BBIO) jointly with VIKING GLOBAL INVESTORS LP, Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, HALVORSEN OLE ANDREAS, Ott David C., Shabet Rose Sharon | Sale (S): 3,500,000 @ $44 | EDGAR |
| 2025-01-31 | 4 | BridgeBio Pharma, Inc. (BBIO) jointly with VIKING GLOBAL INVESTORS LP, Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, HALVORSEN OLE ANDREAS, Ott David C., Shabet Rose Sharon | Sale (S): 3,065,616 @ $34.90 | EDGAR |
| 2024-06-18 | 4 | APi Group Corp (APG) jointly with VIKING GLOBAL INVESTORS LP, Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, HALVORSEN OLE ANDREAS, Ott David C., Shabet Rose Sharon | Sale (S): 1,912,750 @ $38.15 · Sale (S): 39,032 @ $38.15 | EDGAR |
| 2024-06-03 | 4 | Inhibrx, Inc. (INBX) jointly with VIKING GLOBAL INVESTORS LP, Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, HALVORSEN OLE ANDREAS, Ott David C., Shabet Rose Sharon | Other (J): 6,305,866 @ $30 · Other (J): 333,333 @ $30 · Other (J): 511,627 @ $30 · Other (J): 1,038,765 (derivative) @ $30 | EDGAR |
| 2024-03-07 | 4 | APi Group Corp (APG) jointly with VIKING GLOBAL INVESTORS LP, Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, HALVORSEN OLE ANDREAS, Ott David C., Shabet Rose Sharon | Sale (S): 2,977,845 @ $34.25 · Sale (S): 60,772 @ $34.25 | EDGAR |
| 2024-03-01 | 4 | APi Group Corp (APG) jointly with VIKING GLOBAL INVESTORS LP, Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, HALVORSEN OLE ANDREAS, Ott David C., Shabet Rose Sharon | Conversion (C): 8,036,862 @ $24.60 · Conversion (C): 164,016 @ $24.60 · Other (J): 3,983,739 @ $36.90 · Other (J): 81,300 @ $36.90 · Conversion (C): 196,000 (derivative) @ $0 · Conversion (C): 4,000 (derivative) @ $0 | EDGAR |
| 2024-02-28 | 4 | RayzeBio, Inc. (RYZB) jointly with VIKING GLOBAL INVESTORS LP, Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, HALVORSEN OLE ANDREAS, Ott David C., Shabet Rose Sharon | Other (J): 4,899,144 · Other (J): 1,743,556 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1629472 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →